HARLIE HIMMELBERG: Open Payments
NPI 1427772516 · STERLING, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 36 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $399 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $442 |
| Madrigal Pharmaceuticals | 5 | $102 |
| GENZYME CORPORATION | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Gilead Sciences, Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 1 | $44 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| QOL Medical, LLC | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, REZDIFFRA, ENTYVIO, VOQUEZNA, OCALIVA, Sucraid.
Industry payments across CO — which companies pay providers there.
